Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder.
Magalhães PV, Dean OM, Bush AI, Copolov DL, Weisinger D, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.
Magalhães PV, et al. Among authors: copolov dl.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):132-5. doi: 10.1016/j.pnpbp.2011.11.011. Epub 2011 Dec 23.
Prog Neuropsychopharmacol Biol Psychiatry. 2012.
PMID: 22212173
Clinical Trial.